Pharmacological Intervention to Modulate HDL: What Do We Target?

The cholesterol concentrations of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) have traditionally served as risk factors for cardiovascular disease. As such, novel therapeutic interventions aiming to raise HDL cholesterol have been tested in the clinical setting. However, most tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Woudberg, Nicholas J., Pedretti, Sarah, Lecour, Sandrine, Schulz, Rainer, Vuilleumier, Nicolas, James, Richard W., Frias, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786575/
https://www.ncbi.nlm.nih.gov/pubmed/29403378
http://dx.doi.org/10.3389/fphar.2017.00989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786575/
https://www.ncbi.nlm.nih.gov/pubmed/29403378
http://dx.doi.org/10.3389/fphar.2017.00989

Ejemplares similares